UB Paderborn / Katalog / Suche / in CDI

The comprehensive landscape of miR-34a in cancer research

Cancer and metastasis reviews, 2021-09, Vol.40 (3), p.925-948

2021

Link zum Volltext

Verfügbarkeit prüfen

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma

Acta pharmaceutica Sinica. B, 2022-02, Vol.12 (2), p.558-580

2022

Link zum Volltext

Verfügbarkeit prüfen

Plasminogen activator inhibitor-1 in cancer research

Biomedicine & pharmacotherapy, 2018-09, Vol.105, p.83-94

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeting Mitochondrial Metabolic Reprogramming as a Potential Approach for Cancer Therapy

International journal of molecular sciences, 2023-03, Vol.24 (5), p.4954

2023

Link zum Volltext

Verfügbarkeit prüfen

The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer

Investigational new drugs, 2020-04, Vol.38 (2), p.515-524

2020

Link zum Volltext

Verfügbarkeit prüfen

Lactate-activated macrophages induced aerobic glycolysis and epithelial-mesenchymal transition in breast cancer by regulation of CCL5-CCR5 axis: a positive metabolic feedback loop

Oncotarget, 2017-12, Vol.8 (66), p.110426-110443

2017

Link zum Volltext

Verfügbarkeit prüfen

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

World journal of surgical oncology, 2022-02, Vol.20 (1), p.37-37, Article 37

2022

Link zum Volltext

Verfügbarkeit prüfen

Alterations of housekeeping proteins in human aged and diseased hearts

Pflügers Archiv, 2021-03, Vol.473 (3), p.351-362

2021

Link zum Volltext

Verfügbarkeit prüfen

Chemokine C‐C motif receptor 5 and C‐C motif ligand 5 promote cancer cell migration under hypoxia

Cancer science, 2012-05, Vol.103 (5), p.904-912

2012

Link zum Volltext

Verfügbarkeit prüfen

Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma

Frontiers in pharmacology, 2023-02, Vol.14, p.1097277-1097277

2023

Link zum Volltext

Verfügbarkeit prüfen

PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC

Cell death & disease, 2017-10, Vol.8 (10), p.e3143-e3143

2017

Link zum Volltext

Verfügbarkeit prüfen

Tumor-secreted PAI-1 promotes breast cancer metastasis via the induction of adipocyte-derived collagen remodeling

Cell communication and signaling, 2019-06, Vol.17 (1), p.58-58, Article 58

2019

Link zum Volltext

Verfügbarkeit prüfen

Ag120-Mediated Inhibition of ASCT2-Dependent Glutamine Transport has an Anti-Tumor Effect on Colorectal Cancer Cells

Frontiers in pharmacology, 2022-03, Vol.13, p.871392-871392

2022

Link zum Volltext

Verfügbarkeit prüfen

Sepiapterin reductase promotes hepatocellular carcinoma progression via FoxO3a/Bim signaling in a nonenzymatic manner

Cell death & disease, 2020-04, Vol.11 (4), p.248-248, Article 248

2020

Link zum Volltext

Verfügbarkeit prüfen

DT-13 suppresses breast cancer metastasis by modulating PLOD2 in the adipocytes microenvironment

Phytomedicine (Stuttgart), 2019-06, Vol.59, p.152778-152778, Article 152778

2019

Link zum Volltext

Verfügbarkeit prüfen

Arnicolide C Suppresses Tumor Progression by Targeting 14-3-3θ in Breast Cancer

Pharmaceuticals (Basel, Switzerland), 2024-02, Vol.17 (2), p.224

2024

Link zum Volltext

Verfügbarkeit prüfen

Impeding the combination of astrocytic ASCT2 and NLRP3 by talniflumate alleviates neuroinflammation in experimental models of Parkinson's disease

Acta pharmaceutica Sinica. B, 2023-02, Vol.13 (2), p.662-677

2023

Link zum Volltext

Verfügbarkeit prüfen

Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway

Frontiers in pharmacology, 2018-02, Vol.9, p.21-21

2018

Link zum Volltext

Verfügbarkeit prüfen

Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1

Frontiers in pharmacology, 2017-05, Vol.8, p.325-325

2017

Link zum Volltext

Verfügbarkeit prüfen

The retinoid derivant ECPIRM selectively exhibited anti-proliferation effects in cutaneous T-Cell lymphoma via ITK-mediated signaling pathway

Journal of dermatological science, 2020-03, Vol.97 (3), p.208-215

2020

Link zum Volltext

Verfügbarkeit prüfen

A Novel Camptothecin Derivative 3j Inhibits Nsclc Proliferation Via Induction of Cell Cycle Arrest By Topo I-Mediated DNA Damage

Anti-cancer agents in medicinal chemistry, 2019-01, Vol.19 (3), p.365

2019

Link zum Volltext

Verfügbarkeit prüfen

The Saponin Monomer of Dwarf Lilyturf Tuber, DT-13, Reduces Human Breast Cancer Cell Adhesion and Migration during Hypoxia via Regulation of Tissue Factor

Biological and Pharmaceutical Bulletin, 2010/07/01, Vol.33(7), pp.1192-1198

2010

Link zum Volltext

Verfügbarkeit prüfen

Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China

Acta pharmaceutica Sinica. B, 2021-06, Vol.11 (6), p.1526-1540

2021

Link zum Volltext

Verfügbarkeit prüfen

脂质运载蛋白2在肝脏疾病发生发展中的作用

临床肝胆病杂志, 2022-09, Vol.38 (9), p.2177-2181

2022

Link zum Volltext

Verfügbarkeit prüfen

Chemical Constituents of Smilax riparia and their Tumoral Cytotoxicities

Chemistry of natural compounds, 2020-03, Vol.56 (2), p.228-234

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

The comprehensive landscape of miR-34a in cancer research

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma

Plasminogen activator inhibitor-1 in cancer research

Targeting Mitochondrial Metabolic Reprogramming as a Potential Approach for Cancer Therapy

The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer

Lactate-activated macrophages induced aerobic glycolysis and epithelial-mesenchymal transition in breast cancer by regulation of CCL5-CCR5 axis: a positive metabolic feedback loop

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

Alterations of housekeeping proteins in human aged and diseased hearts

Chemokine C‐C motif receptor 5 and C‐C motif ligand 5 promote cancer cell migration under hypoxia

Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma

PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC

Tumor-secreted PAI-1 promotes breast cancer metastasis via the induction of adipocyte-derived collagen remodeling

Ag120-Mediated Inhibition of ASCT2-Dependent Glutamine Transport has an Anti-Tumor Effect on Colorectal Cancer Cells

Sepiapterin reductase promotes hepatocellular carcinoma progression via FoxO3a/Bim signaling in a nonenzymatic manner

DT-13 suppresses breast cancer metastasis by modulating PLOD2 in the adipocytes microenvironment

Arnicolide C Suppresses Tumor Progression by Targeting 14-3-3θ in Breast Cancer

Impeding the combination of astrocytic ASCT2 and NLRP3 by talniflumate alleviates neuroinflammation in experimental models of Parkinson's disease

Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway

Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1

The retinoid derivant ECPIRM selectively exhibited anti-proliferation effects in cutaneous T-Cell lymphoma via ITK-mediated signaling pathway

A Novel Camptothecin Derivative 3j Inhibits Nsclc Proliferation Via Induction of Cell Cycle Arrest By Topo I-Mediated DNA Damage

The Saponin Monomer of Dwarf Lilyturf Tuber, DT-13, Reduces Human Breast Cancer Cell Adhesion and Migration during Hypoxia via Regulation of Tissue Factor

Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China

脂质运载蛋白2在肝脏疾病发生发展中的作用

Chemical Constituents of Smilax riparia and their Tumoral Cytotoxicities

Suchergebnisse filtern